LTR Pharma Launches Roxus ED Nasal Spray in U.S.
LTR Pharma launched a prescription intranasal vardenafil spray in the U.S., available through partner telemedicine platform Mavrox. The compounded product is not FDA-approved.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
LTR Pharma launches Roxus intranasal vardenafil in U.S.
LTR Pharma said Roxus, a compounded intranasal vardenafil for erectile dysfunction, is now available to U.S. prescribers through Strive Pharmacy. The company said the product is dispensed under Section 503A and cited clinical data showing rapid peak plasma levels.